Humana (HUM) Expected to Announce Quarterly Earnings on Tuesday

Humana (NYSE:HUM - Get Free Report) is projected to release its earnings data before the market opens on Tuesday, February 11th. Analysts expect Humana to post earnings of ($2.26) per share and revenue of $28.84 billion for the quarter. Parties that are interested in participating in the company's conference call can do so using this link.

Humana Trading Down 1.7 %

Shares of NYSE:HUM traded down $5.02 during midday trading on Wednesday, hitting $290.52. The company had a trading volume of 1,102,501 shares, compared to its average volume of 1,506,460. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana has a 12 month low of $213.31 and a 12 month high of $406.46. The firm has a fifty day simple moving average of $275.13 and a 200 day simple moving average of $299.72. The stock has a market cap of $34.98 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 2.21 and a beta of 0.56.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent analyst reports. Truist Financial raised their target price on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a report on Monday, January 6th. Sanford C. Bernstein upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective for the company in a report on Tuesday, October 8th. Piper Sandler increased their target price on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Barclays boosted their price target on shares of Humana from $253.00 to $255.00 and gave the company an "equal weight" rating in a report on Wednesday, January 22nd. Finally, Bank of America raised Humana from an "underperform" rating to a "neutral" rating and raised their price target for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, Humana presently has a consensus rating of "Hold" and a consensus target price of $297.68.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.29% of the stock is owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.